@article{pape_immunoneuropsychiatry_2019,
	title = {Immunoneuropsychiatry — novel perspectives on brain disorders},
	volume = {15},
	copyright = {2019 Springer Nature Limited},
	issn = {1759-4766},
	url = {https://www.nature.com/articles/s41582-019-0174-4},
	doi = {10.1038/s41582-019-0174-4},
	abstract = {Immune processes have a vital role in CNS homeostasis, resilience and brain reserve. Our cognitive and social abilities rely on a highly sensitive and fine-tuned equilibrium of immune responses that involve both innate and adaptive immunity. Autoimmunity, chronic inflammation, infection and psychosocial stress can tip the scales towards disruption of higher-order networks. However, not only classical neuroinflammatory diseases, such as multiple sclerosis and autoimmune encephalitis, are caused by immune dysregulation that affects CNS function. Recent insight indicates that similar processes are involved in psychiatric diseases such as schizophrenia, autism spectrum disorder, bipolar disorder and depression. Pathways that are common to these disorders include microglial activation, pro-inflammatory cytokines, molecular mimicry, anti-neuronal autoantibodies, self-reactive T cells and disturbance of the blood–brain barrier. These discoveries challenge our traditional classification of neurological and psychiatric diseases. New clinical paths are required to identify subgroups of neuropsychiatric disorders that are phenotypically distinct but pathogenically related and to pave the way for mechanism-based immune treatments. Combined expertise from neurologists and psychiatrists will foster translation of these paths into clinical practice. The aim of this Review is to highlight outstanding findings that have transformed our understanding of neuropsychiatric diseases and to suggest new diagnostic and therapeutic criteria for the emerging field of immunoneuropsychiatry.},
	language = {en},
	number = {6},
	urldate = {2021-04-08},
	journal = {Nature Reviews Neurology},
	author = {Pape, Katrin and Tamouza, Ryad and Leboyer, Marion and Zipp, Frauke},
	month = jun,
	year = {2019},
	note = {ZSCC: 0000105 
Number: 6
Publisher: Nature Publishing Group},
	pages = {317--328},
}

{"_id":"P5bjaxYy2vaSkCGus","bibbaseid":"pape-tamouza-leboyer-zipp-immunoneuropsychiatrynovelperspectivesonbraindisorders-2019","author_short":["Pape, K.","Tamouza, R.","Leboyer, M.","Zipp, F."],"bibdata":{"bibtype":"article","type":"article","title":"Immunoneuropsychiatry — novel perspectives on brain disorders","volume":"15","copyright":"2019 Springer Nature Limited","issn":"1759-4766","url":"https://www.nature.com/articles/s41582-019-0174-4","doi":"10.1038/s41582-019-0174-4","abstract":"Immune processes have a vital role in CNS homeostasis, resilience and brain reserve. Our cognitive and social abilities rely on a highly sensitive and fine-tuned equilibrium of immune responses that involve both innate and adaptive immunity. Autoimmunity, chronic inflammation, infection and psychosocial stress can tip the scales towards disruption of higher-order networks. However, not only classical neuroinflammatory diseases, such as multiple sclerosis and autoimmune encephalitis, are caused by immune dysregulation that affects CNS function. Recent insight indicates that similar processes are involved in psychiatric diseases such as schizophrenia, autism spectrum disorder, bipolar disorder and depression. Pathways that are common to these disorders include microglial activation, pro-inflammatory cytokines, molecular mimicry, anti-neuronal autoantibodies, self-reactive T cells and disturbance of the blood–brain barrier. These discoveries challenge our traditional classification of neurological and psychiatric diseases. New clinical paths are required to identify subgroups of neuropsychiatric disorders that are phenotypically distinct but pathogenically related and to pave the way for mechanism-based immune treatments. Combined expertise from neurologists and psychiatrists will foster translation of these paths into clinical practice. The aim of this Review is to highlight outstanding findings that have transformed our understanding of neuropsychiatric diseases and to suggest new diagnostic and therapeutic criteria for the emerging field of immunoneuropsychiatry.","language":"en","number":"6","urldate":"2021-04-08","journal":"Nature Reviews Neurology","author":[{"propositions":[],"lastnames":["Pape"],"firstnames":["Katrin"],"suffixes":[]},{"propositions":[],"lastnames":["Tamouza"],"firstnames":["Ryad"],"suffixes":[]},{"propositions":[],"lastnames":["Leboyer"],"firstnames":["Marion"],"suffixes":[]},{"propositions":[],"lastnames":["Zipp"],"firstnames":["Frauke"],"suffixes":[]}],"month":"June","year":"2019","note":"ZSCC: 0000105 Number: 6 Publisher: Nature Publishing Group","pages":"317–328","bibtex":"@article{pape_immunoneuropsychiatry_2019,\n\ttitle = {Immunoneuropsychiatry — novel perspectives on brain disorders},\n\tvolume = {15},\n\tcopyright = {2019 Springer Nature Limited},\n\tissn = {1759-4766},\n\turl = {https://www.nature.com/articles/s41582-019-0174-4},\n\tdoi = {10.1038/s41582-019-0174-4},\n\tabstract = {Immune processes have a vital role in CNS homeostasis, resilience and brain reserve. Our cognitive and social abilities rely on a highly sensitive and fine-tuned equilibrium of immune responses that involve both innate and adaptive immunity. Autoimmunity, chronic inflammation, infection and psychosocial stress can tip the scales towards disruption of higher-order networks. However, not only classical neuroinflammatory diseases, such as multiple sclerosis and autoimmune encephalitis, are caused by immune dysregulation that affects CNS function. Recent insight indicates that similar processes are involved in psychiatric diseases such as schizophrenia, autism spectrum disorder, bipolar disorder and depression. Pathways that are common to these disorders include microglial activation, pro-inflammatory cytokines, molecular mimicry, anti-neuronal autoantibodies, self-reactive T cells and disturbance of the blood–brain barrier. These discoveries challenge our traditional classification of neurological and psychiatric diseases. New clinical paths are required to identify subgroups of neuropsychiatric disorders that are phenotypically distinct but pathogenically related and to pave the way for mechanism-based immune treatments. Combined expertise from neurologists and psychiatrists will foster translation of these paths into clinical practice. The aim of this Review is to highlight outstanding findings that have transformed our understanding of neuropsychiatric diseases and to suggest new diagnostic and therapeutic criteria for the emerging field of immunoneuropsychiatry.},\n\tlanguage = {en},\n\tnumber = {6},\n\turldate = {2021-04-08},\n\tjournal = {Nature Reviews Neurology},\n\tauthor = {Pape, Katrin and Tamouza, Ryad and Leboyer, Marion and Zipp, Frauke},\n\tmonth = jun,\n\tyear = {2019},\n\tnote = {ZSCC: 0000105 \nNumber: 6\nPublisher: Nature Publishing Group},\n\tpages = {317--328},\n}\n\n","author_short":["Pape, K.","Tamouza, R.","Leboyer, M.","Zipp, F."],"key":"pape_immunoneuropsychiatry_2019","id":"pape_immunoneuropsychiatry_2019","bibbaseid":"pape-tamouza-leboyer-zipp-immunoneuropsychiatrynovelperspectivesonbraindisorders-2019","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41582-019-0174-4"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/saracatanese","dataSources":["eTsH756eicg6vxuG3","5Q3QAaq7NKyE2QC5S"],"keywords":[],"search_terms":["immunoneuropsychiatry","novel","perspectives","brain","disorders","pape","tamouza","leboyer","zipp"],"title":"Immunoneuropsychiatry — novel perspectives on brain disorders","year":2019}